{"id":"W4322771858","doi":"10.1158/1538-7445.sabcs22-p1-11-19","title":"Abstract P1-11-19: A real-world evidence study of treatment patterns in patients with HER2-positive metastatic breast cancer who have received at least 2-lines of therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; AstraZeneca (Canada)","funders":"","keywords":"Medicine; Metastatic breast cancer; Pertuzumab; Trastuzumab; Discontinuation; Internal medicine; Oncology; Breast cancer; Cancer; Interquartile range","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005684157,0.0003035175,0.0008932264,0.00223166,0.0004030328,0.001676335,0.000741848,0.0006292681,0.005007059],"category_scores_gemma":[0.02673538,0.0002443367,0.002146798,0.005321437,0.0003606328,0.001381938,0.0008598394,0.0007908787,0.0004138665],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001066379,"about_ca_system_score_gemma":0.001869892,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002767268,"about_ca_topic_score_gemma":0.004393413,"domain_scores_codex":[0.9932963,0.002960535,0.001749496,0.0008305539,0.0009585859,0.0002045351],"domain_scores_gemma":[0.9608523,0.01522937,0.01916751,0.0008949885,0.002563496,0.001292296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0078506,0.0003599777,0.9361178,0.008249334,0.0126886,0.000190739,0.0001909496,0.0004335755,0.0001952613,0.0002831269,0.003932438,0.02950756],"study_design_scores_gemma":[0.002197637,0.003091843,0.9637832,0.006180191,0.01066368,0.0007761978,0.0008712196,0.001137905,0.0002589191,0.0004557547,0.0105289,0.00005453456],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8772103,0.05966685,0.001210804,0.00256776,0.0001294695,0.001115589,0.0531553,0.00002590371,0.004918034],"genre_scores_gemma":[0.9824976,0.00585664,0.0008722161,0.0005002493,0.00009217385,0.0006748367,0.009216648,0.000007401833,0.000282236],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005684157,"threshold_uncertainty_score":0.03006101,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1398723184148304,"score_gpt":0.4563584420705444,"score_spread":0.3164861236557139,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}